Australian Panel Recommends Science Revamp

A government-created committee suggests that Australia reinvigorate its biomedical research enterprise.

Written byBob Grant
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

Wikimedia, Paul TempletonA panel of experts convened last year by the Australian government and tasked with generating ideas that would advance the country's health and medical research efforts over the next decade has released a 21-point draft plan that would provide a serious boost to Australian scientists if implemented. The plan, drafted by the Strategic Review of Health and Medical Research in Australia, includes recommendations to create 1000 new fellowships for clinicians to devote more time to research and establishing 20 new biomedical research institutions.

The panel also suggests investing at least 3 percent of federal, state, and territory government health funding to biomedical research, a boost that could total AUD $2-3 billion by 2023.

Unsurprisingly, Australian researchers are keen on the recommendations. "We particularly applaud the panel's recommendation to increase public sector investment in research over the next decade," Brendan Crabb, president-elect for the Association for Australian Medical Research Institutes, told The Sydney Morning Herald.

But how the initiatives will be funded is a huge question, especially since the Australian government is currently toying with the idea of freezing research grants as a part of wider austerity measures. The Australian public has until the end of the month (October 31) to register comments on the draft plan before it's ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

  • From 2017 to 2022, Bob Grant was Editor in Chief of The Scientist, where he started in 2007 as a Staff Writer. Before joining the team, he worked as a reporter at Audubon and earned a master’s degree in science journalism from New York University. In his previous life, he pursued a career in science, getting a bachelor’s degree in wildlife biology from Montana State University and a master’s degree in marine biology from the College of Charleston in South Carolina. Bob edited Reading Frames and other sections of the magazine.

    View Full Profile
Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies